I have been working on the epidemiology of Gram-negative bacilli, the characterization of their resistance mechanisms, and the evaluation of diagnostic tools for their identification since 2011. Over the years, I was involved in projects studying important nosocomial and community-acquired pathogens, such as carbapenemase-producing Enterobacteriales and Acinetobacter spp., as well as Neisseria gonorrhoeae. During my PhD, I characterized the genetic background mediating colistin resistance in A. baumannii and improved my knowledge on high-throughput sequencing methodologies and genomic data analysis. Since I joined IP, in November 2020, I have been evaluating the dynamics of mobile genetic elements associated with the emergence of antimicrobial resistance in historical Enteropathogenic Escherichia coli.
PhD in Sciences – Translational Medicine, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. Title of the Thesis: Molecular characterization of polymyxin resistance mechanisms among multidrug resistant Acinetobacter baumannii. Advisor: Ana Cristina Gales. Apr/2016-May/2020.
Master in Pharmaceutical Sciences, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil. Title of the Dissertation: Resistome analysis of carbapenemase-producing Enterobacteriaceae using Next-Generation Sequencing. Advisor: Afonso Luís Barth. Apr/2014-Mar/2016.
Bachelor’s in Pharmacy, UFRGS, Porto Alegre, Brazil. Project title: Frequency of imipenem heteroresistance among KPC-producing Enterobacteriaceae. Advisor: Afonso Luís Barth. Mar/2008-Dec/2013.
Co-advisor of the master’s dissertation of Felipe Alberto Lei, at the Federal University of São Paulo. Research topic: Diversity of carbapenemases among clinical isolates belonging to Pseudomonas putida group. Advisor: Ana Cristina Gales. Aug/2018-Dec/2020.
Co-advisor of the bachelor’s final project of Larissa Akie Natsumeda, at the Federal University of São Paulo. Research topic: Azithromycin resistance mechanisms among Neisseria gonorrhoeae clinical isolates. Advisor: Ana Cristina Gales. Mar/2018-Dec/2018.
Co-advisor of the bachelor’s final project of Lisiane Rech Pancotto, at the Federal University of Rio Grande do Sul. Research topic: Rapid phenotypic detection of carbapenemases among Enterobacteriaceae clinical isolates. Advisor: Afonso Luís Barth. Mar/2015-Dec/2015.
Assistant professor in the Clinical Bacteriology course, offered to Pharmacy students at the Federal University of Rio Grande do Sul. Teaching hours: 30 hours. Aug-Dec/2014.
In the last 3 years (2019-2021): 18
Total citations: 205 (as of 14.12.21)
Conference poster and oral presentations
In the last 3 years (2019-2021): 19
Presenting author: 11
Member of editorial board
German Journal of Microbiology (since 2021)
Biomedicine & Pharmacotherapy (since 2021)
Gene Reports (since 2021)
Frontiers in Cellular in Infection Microbiology (since 2021)
Microbial Pathogenesis (since 2021)
Journal of Microbiological Methods (since 2021)
Access Microbiology (since 2020)
Revista do Instituto de Medicina Tropical de São Paulo (since 2020)
Journal of Chemotherapy (since 2020)
Journal of Hospital Infection (since 2020)
Microbial Drug Resistance (since 2020)
Brazilian Journal of Microbiology (since 2020)
Medical Microbiology and Immunology (since 2019)
mSphere (since 2019)
Canadian Journal of Infectious Diseases & Medical Microbiology (since 2019)
Antimicrobial Agents and Chemotherapy (since 2019)
Journal of Medical Microbiology (since 2018)
Journal of Antimicrobial Chemotherapy (since 2018)
Journal of Global Antimicrobial Resistance (since 2017)
The Brazilian Journal of Infectious Diseases (since 2016)
2021pmrCAB Recombination Events among Colistin-Susceptible and -Resistant Acinetobacter baumannii Clinical Isolates Belonging to International Clone 7., mSphere 2021 Dec; 6(6): e0074621.
2021Genomic analysis of carbapenem-resistant Pseudomonas aeruginosa ST143 clone showing susceptibility to broad-spectrum cephalosporins., J Glob Antimicrob Resist 2021 09; 26(): 177-179.
2021In vitro activity of sulbactam/durlobactam against extensively drug-resistant Acinetobacter baumannii isolates belonging to South American major clones., J Glob Antimicrob Resist 2021 06; 25(): 363-366.
2021In vitro synergy of ticarcillin/clavulanate in combination with aztreonam and ceftolozane/tazobactam against SPM-1-producing Pseudomonas aeruginosa strains., Diagn Microbiol Infect Dis 2021 Jun; 100(2): 115343.
2021Outbreak of Acinetobacter colistiniresistens bloodstream infections in a neonatal intensive care unit., J Glob Antimicrob Resist 2021 03; 24(): 257-259.
2021Dynamic of High-Risk Acinetobacter baumannii Major Clones in a Brazilian Tertiary Hospital During a Short Time Period., Microb Drug Resist 2021 Mar; 27(3): 320-327.
2020In vitro synergy of ceftolozane/tazobactam in combination with fosfomycin or aztreonam against MDR Pseudomonas aeruginosa., J Antimicrob Chemother 2020 07; 75(7): 1874-1878.
2020Virulence Potential of a Multidrug-Resistant Escherichia coli Strain Belonging to the Emerging Clonal Group ST101-B1 Isolated from Bloodstream Infection., Microorganisms 2020 May; 8(6): .
2020Diversity of amino acid substitutions in PmrCAB associated with colistin resistance in clinical isolates of Acinetobacter baumannii., Int J Antimicrob Agents 2020 Mar; 55(3): 105862.
2020Genomic Analysis of Carbapenem-Resistant Acinetobacter baumannii Isolates Belonging to Major Endemic Clones in South America., Front Microbiol 2020 ; 11(): 584603.
+View full list of publications